CirCode Biomed gains clearance from FDA for RNA drug HM2002
CirCode Biomed’s circular RNA drug HM2002 has received IND clearance from the FDA for the treatment of ischaemic heart disease.
CirCode Biomed’s circular RNA drug HM2002 has received IND clearance from the FDA for the treatment of ischaemic heart disease.
What's Your Reaction?
